Mutya Harsch - Mar 20, 2023 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Chief Legal Officer and GC
Signature
/s/ Mutya Harsch
Stock symbol
VYNE
Transactions as of
Mar 20, 2023
Transactions value $
$25,000
Form type
4
Date filed
3/22/2023, 04:01 PM
Previous filing
Jan 4, 2023
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Purchase $25K +10K +78.61% $2.50 22.7K Mar 20, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split.